glutathione and the brain transporter-mediated targeting prodrug brain Changes in levels of the

GHK-Cu's role as a carrier peptide means it's less about direct messaging and more about providing a fundamental building block (copper) that the body then uses for its regenerative processes

MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive

Species differences in peptide metabolism, receptor density, and clearance pathways mean that a compound safe in rats could, in theory, produce unexpected toxicity in humans

At the lowest dose of 0.3 mg weekly, roughly 20% of participants experienced nausea

( [ \- Link Opens in New Tab]( 11